VTR Biotech successfully participated in VIV Asia 2025, one of the premier international events for the animal feed and ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

Apollomics has sold the rights to its lead c-MET inhibitor in Asia, excluding Greater China ... The Foster City, Calif.-based biotech had already given up hope for the therapy, from which it ...

the award recognizes Amaran Biotech’s outstanding contribution to advancing automated aseptic filling solutions in the biopharmaceutical sector. The Taiwan Biopharma Excellence Awards celebrate ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech ... at the Asia-Pacific Biopharma ...

organizations and technologies across Asia. The awards aim to foster the advancement of the biopharmaceutical industry. Amaran Biotech’s high-purity AB-801 adjuvant, produced through its ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology buzzwords and hype have lost their shine in pharma, and the spotlight is now ...

The biotechnology sector is inherently volatile, influenced by several key industry factors. Clinical trial outcomes are a major driver of stock price fluctuations, as success or failure can ...

National Biotechnology Month proved no different. The sector was active with five healthcare companies raising $800 million in the first few weeks of 2025 alone. "The momentum we're seeing in ...

As global markets navigate a landscape marked by cautious investor sentiment and mixed economic signals, the Asian tech sector stands out as a dynamic area with potential for significant growth. In ...